Beta2-microglobulin(B2M) in cancer immunotherapies: Biological function, resistance and remedy - ScienceDirect
Yair Einhorn on Twitter: "5/CB-011 is an allogeneic anti-BCMA CAR-T #CellTherapy using #Cas12a #chRDNA technology to insert a BCMA-specific CAR into the TRAC gene & armor the cells with an immune cloaking
B-NDG B2m KO mice plus - Biocytogen
Beta-2 Microglobulin
Beta-2 microglobulin - Wikipedia
B2M gene knockout in HEK293T cells by non-viral delivery of CRISPR-Cas9 for the induction of universal cell
Beta-2 microglobulin Protein Overview: Sequence, Structure, Function and Protein Interaction | Sino Biological
Universal donor cells – a revolution against rejection
The B2M Gene Is Targeted by Genetic Alterations in DLBCL (A) Schematic... | Download Scientific Diagram
Inactivation of the B2M gene is recurrent in lung cancer and may condition the response to immunotherapy – IDIBELL
Frontiers | The immune-related role of beta-2-microglobulin in melanoma
CRISPR/Cas9 and AAV mediated insertion of β2 microglobulin-HLA-G fusion gene protects mesenchymal stromal cells from allogeneic rejection and potentiates the use for off-the-shelf cell therapy - ScienceDirect
Evolving neoantigen profiles in colorectal cancers with DNA repair defects | Genome Medicine | Full Text
B2M (beta-2-microglobulin) | Gene Report | BioGPS
CRISPR/Cas9 and AAV mediated insertion of β2 microglobulin-HLA-G fusion gene protects mesenchymal stromal cells from allogeneic rejection and potentiates the use for off-the-shelf cell therapy - ScienceDirect
Beta-2 Microglobulin (B2M) Test in Delhi, India | GDIC
B2M Gene - GeneCards | B2MG Protein | B2MG Antibody